{"database": "openregs", "table": "documents", "rows": [["FDA-1975-N-0012-0028", "FDA", "FDA-1975-N-0012", "Tab H - \"Alcavis International, Inc. Letter to FDA, June 17, 2003\" - [Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC)", "Supporting & Related Material", "Background Material", "2009-12-22T05:00:00Z", 2009, 12, null, null, "2017-11-29T20:50:56Z", null, 0, 0, "0900006480a4d459"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-1975-N-0012-0028"], "units": {}, "query_ms": 0.422515906393528, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}